Gladius Capital Management »

Amneal Pharmaceuticals shares owned by Gladius Capital Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Gladius Capital Management from 13F filings

Historical chart of Gladius Capital Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Gladius Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Gladius Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 8.0k 6.07
2023-09-30 $39k 9.2k 4.22
2022-09-30 $34k 17k 2.05

More positions owned by Gladius Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Put Put Option
Apple Put Put Option
Microsoft Corp Put Put Option
Ishares Gold Tr Ishares New (IAU)
Apple Call Call Option
Advanced Micro Devices Put Put Option
Alphabet Put Put Option
Micron Technology Put Put Option
Nvidia Corporation Put Put Option
Microsoft Corp Call Call Option
Amazon Call Call Option
Amazon Put Put Option
Broadcom Put Put Option
Meta Platforms Put Put Option

View all positions for Gladius Capital Management

Top funds holding Amneal Pharmaceuticals

Fosun International
Vanguard Group
Tpg Gp A
Citadel Advisors
Neuberger Berman Group
Dimensional Fund Advisors
Nantahala Capital Management
Charles Schwab Investment Management
LSV Asset Management
AQR Capital Management
Teacher Retirement System Of Texas
Phocas Financial
D. E. Shaw & Co
Russell Investments
Bank of New York Mellon

View all funds holding Amneal Pharmaceuticals